Jarrett BurksJarrettBurks

Caithness Energy in an agreement to sell its Moxie Freedom Energy Center in Pennsylvania and Caithness Energy and BlackRock’s Guernsey Power Station in Ohio to Talen Energy Corporation ($3.8 billion).

Allovue, Inc. in connection with its sale to PowerSchool Promachos Holding, Inc. d/b/a PowerSchool (NYSE: PWSC) ($42 million).

Alvotech in connection with its agreement to merge with Oaktree Acquisition Corp. II (NYSE: OACB) ($2.25 billion).

Ascend Advanced Therapies Limited in connection with its acquisition of Advanced BioScience Laboratories, Inc. (ABL).

Athenex, Inc. (NASDAQ: ATNX) in connection with its acquisition of Kuur Therapeutics, Inc. ($185 million).

Bavarian Nordic A/S (OMX: BAVA) in connection with its acquisition of Emergent BioSolutions, Inc.’s (NYSE: EBS) travel vaccines portfolio, including VIVOTIF®, VAXCHORA® and a development-stage chikungunya vaccine candidate (up to $380 million).

biote Corp. in connection with its agreement to merge Haymaker Acquisition Corp. III (NASDAQ: HYAC) ($737 million).

Causal, Inc. in connection with its sale to LucaNet Holding GmbH.

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) in connection with its acquisition of certain assets from Eisai Co., Ltd., including the U.S. rights for FYCOMPA® (perampanel) CIII and an exclusive option period to acquire a rare epilepsy asset (up to $185 million + royalties).

Evox Therapeutics Ltd. in connection with its acquisition of certain assets sold out of Codiak BioSciences, Inc.’s bankruptcy proceedings, including Codiak’s engEx-AAV™ technology platform.

MacroGenics, Inc. (NASDAQ: MGNX) in connection with its sale of certain assets, including the global rights to MARGENZA® (margetuximab-cmkb TerSera Therapeutics LLC (up to $75 million).

Malk Sustainability Partners, Inc. in connection with its sale to SLR International Corp.

Oculis Holdings AG in connection with its agreement to merge with European Biotech Acquisition Corp. (NASDAQ: EBAC) ($248 million).

Rooam, Inc. in connection with its sale to American Express Travel Related Services Company, Inc. (NYSE: AXP).

SEDNA Communications Ltd. in connection with its acquisition of certain assets from Boxton, Inc., including its email automation solution, Shelly.

A group of investors led by Stride Capital in connection with the sale of Hofy LTD. to Deel, Inc.

Toluna Holdings Limited in connection with its acquisition of Brainyak, Inc. d/b/a Gutcheck ($45 million).

ZOLL Medical Corporation in connection with its acquisition of Itamar Medical Ltd. (NASDAQ and TASE: ITMR) ($538 million).

RedHill Biopharma, Inc. (NASDAQ: RDHL) in connection with its acquisition of certain assets from AstraZeneca AB (NYSE: AZN), including a sublicense to the global rights to Movantik® (naloxegol) ($67.5 million).

Becle S.A.B. de C.V. d/b/a Jose Cuervo (BMV:CUERVO) in connection with its acquisition of the Canadian whisky brand Pendleton from Hood River Distillers, Inc. ($208 million).

Linde AG (FWB: LIN) in connection with its “merger of equals” with Praxair, Inc. (NYSE: LIN) ($90 billion).

Rock-Tenn Company in connection with its combination with MeadWestvaco Corporation to create WestRock Company (NYSE: WRK) ($16 billion).

The Spectranetics Corporation (NASDAQ: SPNC) in connection with its sale to Royal Philips (NYSE: PHG and AEX: PHIA) (€1.9 billion).